Drug Profile
Tisokinase
Alternative Names: AK 124; Hapase; PlasvataLatest Information Update: 22 Apr 2016
Price :
$50
*
At a glance
- Originator Asahi Kasei
- Developer Asahi Kasei; Kowa
- Class Plasminogen activator enzymes; Thrombolytics
- Mechanism of Action Plasminogen activator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Intracranial thrombosis; Myocardial infarction
Most Recent Events
- 15 Jan 2001 Asahi Chemical is now called Asahi Kasei
- 12 Jan 1996 Launched for Cerebral thrombosis in Japan (IV)
- 05 Jan 1996 Launched for Myocardial infarction in Japan (Intra-arterial)